In Need Of Evidence: Medicare Panel Prioritizes Research Efforts
This article was originally published in The Gray Sheet
Executive Summary
Top research priorities for the elderly should include looking at carotid artery stenting, radiation therapy and prognostic markers for cancer, as well as a number of other areas applicable to devices and diagnostics, says the Medicare Evidence Development and Coverage Advisory Committee
You may also be interested in...
CMS’ “Potential” NCD List Gets Stakeholder Support, But Questions Remain
The device industry and other Medicare stakeholders are generally supportive of CMS' recent move to publicize topics it is considering for future national coverage determinations, though some worry that the agency will use the process to limit patient access to technologies
CMS’ “Potential” NCD List Gets Stakeholder Support, But Questions Remain
The device industry and other Medicare stakeholders are generally supportive of CMS' recent move to publicize topics it is considering for future national coverage determinations, though some worry that the agency will use the process to limit patient access to technologies
CMS Plans Response To Industry Concerns Over MedCAC Process
CMS will more fully describe how it intends to use its Medicare Evidence Development and Coverage Advisory Committee to set research priorities, CMS Chief Medical Officer Barry M. Straube said April 30 at a MedCAC meeting in Baltimore